secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001185185-23-000688
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma raises $3M in private placement of 10M shares at $0.30/sh
--------------------------------------------------------------------

- Gross proceeds of $3M from Bradbury Asset Management (≈$2B AUM) and three other investors.
- 10 million unregistered common shares at $0.30 each; no warrants or derivatives included.
- Funds to advance Phase-2 clinical trial of IGC-AD1 for agitation in Alzheimer's dementia.
- Closing subject to NYSE approval; strengthens working capital for pipeline development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518523000688/0001185185-23-000688-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518523000688/igcpharma20230706_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-23-000688

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer